Professor, Internal Medicine, Northeastern Ohio Medical Univ
Infectious Disease
Dr. Thomas M. File Jr., MD
|
|
Give Review
Thomas M. File Jr. works in the field of Infectious Disease. He went to University of Michigan Medical School. He received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Thomas File is a published doctor and has 56 publications published. The lastest was: 'Assessment of Time to Clinical Response, a Proxy for Discharge Readiness, among Hospitalized Patients with Community Acquired Pneumonia (CAP) Who Received either Cefta...' Thomas M. File Jr. is registered with Medicare and accepts Medicare payments.
Publications
- Guidance for the knowledge and skills required for antimicrobial stewardship leaders.
- Assessment of Time to Clinical Response, a Proxy for Discharge Readiness, among Hospitalized Patients with Community Acquired Pneumonia (CAP) Who Received either Cefta...
- Effect of Introducing Procalcitonin on Antimicrobial Therapy Duration in Patients With Sepsis and/or Pneumonia in the Intensive Care Unit.
- Another perspective: Reducing the overtreatment of pneumonia.
- Does Empiric Therapy for Atypical Pathogens Improve Outcomes for Patients with CAP?
- Determining the Duration of Therapy for Patients with Community-Acquired Pneumonia.
- Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.
- An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): place in therapy.
- Summary of ceftaroline fosamil clinical trial studies and clinical safety.
- A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneu...
- New Diagnostic Tests for Pneumonia: What is Their Role in Clinical Practice?
- Improving clinical practice guidelines--the answer is more clinical research.
- Strategies for improving antimicrobial use and the role of antimicrobial stewardship programs.
- Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxon...
- Keeping our adult patients healthy and active: the role of vaccines across the lifespan.
- Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
- Performance measure of urinary antigen in patients with Streptococcus pneumoniae bacteremia.
- Case studies of lower respiratory tract infections: community-acquired pneumonia.
- Burden of community-acquired pneumonia in North American adults.
- Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.
- Safety of intravenous infusion of doripenem.
- The science of selecting antimicrobials for community-acquired pneumonia (CAP).
- Prevention of bloodstream infections: basics and beyond.
- What can we learn from the time course of untreated and partially treated community-onset Streptococcus pneumoniae pneumonia? A clinical perspective on superiority and...
- Is the risk of serious infections increased in patients with RA who receive treatment with antirheumatic drugs?
- Impact of community-acquired methicillin-resistant Staphylococcus aureus in the hospital setting.
- Performance measurement in community-acquired pneumonia: consequences intended and unintended.
- How long should we treat community-acquired pneumonia?
- Prevalence and antibacterial susceptibility of mef(A)-positive macrolide-resistant Streptococcus pneumoniae over 4 years (2000 to 2004) of the PROTEKT US Study.
- Medication options for the treatment of CAP.
- Ventilator-associated pneumonia: gearing towards shorter-course therapy.
- The clinical relevance of penicillin-resistant Streptococcus pneumoniae: a new perspective.
- Optimizing therapy for community-acquired pneumonia with the goal of rapid resolution of illness.
- Pneumonia in older adults: reversing the trend.
- Community-associated methicillin-resistant Staphylococcus aureas: not only a cause of skin infections, also a new cause of pneumonia.
- Telithromycin new product overview.
- Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomiz...
- Solutions to the problem of bacterial resistance.
- Severe acute respiratory syndrome: pertinent clinical characteristics and therapy.
- Antimicrobial therapy of community-acquired pneumonia.
- Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia.
- Streptococcus pneumoniae and community-acquired pneumonia: a cause for concern.
- Evolution of amoxicillin/clavulanate in the treatment of adults with acute bacterial rhinosinusitis and community-acquired pneumonia in response to antimicrobial-resis...
- Guidelines for empiric antimicrobial prescribing in community-acquired pneumonia.
- Shorter course therapy of serious respiratory infections: new data for new approaches to management.
- Short-course treatment of community-acquired pneumonia.
- Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia.
- Viral respiratory tract infections: increasing importance and a new pathogen.
- What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?
- A new dosing paradigm: high-dose, short-course fluoroquinolone therapy for community-acquired pneumonia.
- Legionnaires disease with bacteremic coinfection.
- Rational use of antibiotics to treat respiratory tract infections.
- Etiology and management of community-acquired pneumonia in Asia.
- Judicious use of antibiotics to treat respiratory tract infections.
- New millennium: new antimicrobial agents for respiratory infections; but an old plea.
Schools
University Of Michigan Medical School
Riverside Methodist Hospital
Ohio State University
The Ohio State University Medical Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Ohio State University Hospital -
Riverside Methodist Hospitals - OhioHealth -
University of Michigan Medical School
Hospital
-
Summa Akron City Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Gary E. Bollin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jill E. Miracle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aimee L. Mandapat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shanu Agarwal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hector F. Bonilla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Munshi Moyenuddin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose E. Poblete, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Latasha Naidu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nikole Scalera, MD
This Doctor is OpenDoctor Recommended.
|